Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deyang Sinozyme Pharmaceutical is a specialized Chinese pharmaceutical company focused on the research, development, and large-scale production of biochemical APIs and enzymes. Founded in 1993 and based in Deyang, Sichuan, the company is a leading manufacturer of animal-derived enzymes, including Pancreatin, Chymotrypsin, Trypsin, and Pepsin. These products are essential components in digestive aids, anti-inflammatory medications, and wound care treatments. The company operates GMP-certified facilities and maintains a strong international presence, exporting high-purity biological extracts that comply with major global pharmacopeia standards. Their portfolio serves a wide range of therapeutic areas, primarily focusing on gastroenterology and dermatology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Deyang Sinozyme Pharmaceutical.